NCT05570253 2026-04-17A Study of SDX-7320 in Combination With Eribulin for People With Breast CancerMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting55 enrolled
NCT04345913 2026-04-13Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast CancerNational Cancer Institute (NCI)Phase 1/2 Active not recruiting24 enrolled 24 charts